Fourth State is a UK-based startup founded in 2012 with the mission of making Reactive Oxygen and Nitrogen Species (RONS) accessible with just air and electricity. The company offers Ozone and NOx gas generators utilizing patented Air Plasma technology, which have antimicrobial, bioactive, and chemical effects applicable to various industries including Biotechnology, Health Care, Medical Devices, and Robotics.
Their technology, developed and validated in the UK with leading universities and grant funders, is manufactured to ISO9001 standards. The company's last investment was a grant received on February 2, 2017. Fourth State targets businesses and researchers interested in using RONS for research, combating pathogens, improving patient health outcomes, and increasing process yields. The startup emphasizes the user-friendliness, automation, portability, and sustainability of their in-situ generators compared to other sources of RONS.
Customers can access their technology through modular OEM components and fully-integrated laboratory equipment. Fourth State welcomes innovators of all backgrounds to engage with them through their website, www.fourth-state.com. With a focus on creating a healthier and greener world, the company aims to expand its impact in various industries, offering a promising investment opportunity for venture capitalists seeking to support sustainable and innovative solutions in biotechnology and healthcare.